Literature DB >> 29684359

The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands.

Ching-Shuen Wang1, Olga J Baker2.   

Abstract

Lipoxin receptor (ALX)/N-formyl peptide receptor (FPR)-2 is a G-protein-coupled receptor that has multiple binding partners, including the endogenous lipid mediators resolvin D1, lipoxin A4, and the Ca2+-dependent phospholipid-binding protein annexin A1. Previous studies have demonstrated that resolvin D1 activates ALX/Fpr2 to resolve salivary gland inflammation in the NOD/ShiLtJ mouse model of Sjögren syndrome. Moreover, mice lacking the ALX/Fpr2 display an exacerbated salivary gland inflammation in response to lipopolysaccharide. Additionally, activation of ALX/Fpr2 has been shown to be important for regulating antibody production in B cells. These previous studies indicate that ALX/Fpr2 promotes resolution of salivary gland inflammation while modulating adaptive immunity, suggesting the need for investigation of the role of ALX/Fpr2 in regulating antibody production and secretory function in mouse salivary glands. Our results indicate that aging female knockout mice lacking ALX/Fpr2 display a significant reduction in saliva flow rates and weight loss, an increased expression of autoimmune-associated genes, an up-regulation of autoantibody production, and increased CD20-positive B-cell population. Although not all effects were noted among the male knockout mice, the results nonetheless indicate that ALX/Fpr2 is clearly involved in the adaptive immunity and secretory function in salivary glands, with further investigation warranted to determine the cause(s) of these between-sex differences.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29684359      PMCID: PMC6024187          DOI: 10.1016/j.ajpath.2018.04.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  57 in total

1.  The role of BAFF in B-cell maturation, T-cell activation and autoimmunity.

Authors:  Fabienne Mackay; Charles R Mackay
Journal:  Trends Immunol       Date:  2002-03       Impact factor: 16.687

Review 2.  Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.

Authors:  T P Gordon; A I Bolstad; M Rischmueller; R Jonsson; S A Waterman
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

Review 3.  Antinuclear antibodies in Sjögren's syndrome.

Authors:  E K Chan; L E Andrade
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

Review 4.  Docosahexaenoic acid, protectins and dry eye.

Authors:  Maria S Cortina; Haydee E P Bazan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

5.  The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.

Authors:  J He; L Qiang; Y Ding; P Wei; Y N Li; H Hua; Z G Li
Journal:  Clin Exp Rheumatol       Date:  2012-06-25       Impact factor: 4.473

6.  Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.

Authors:  Amiram Ariel; Nan Chiang; Makoto Arita; Nicos A Petasis; Charles N Serhan
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

7.  Novel autoantibodies in Sjogren's syndrome.

Authors:  Long Shen; Lakshmanan Suresh; Matthew Lindemann; Jingxiu Xuan; Przemek Kowal; Kishore Malyavantham; Julian L Ambrus
Journal:  Clin Immunol       Date:  2012-10-12       Impact factor: 3.969

8.  Laminin-111-derived peptide conjugated fibrin hydrogel restores salivary gland function.

Authors:  Kihoon Nam; Christina L Maruyama; Ching-Shuen Wang; Bryan G Trump; Pedro Lei; Stelios T Andreadis; Olga J Baker
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

9.  AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.

Authors:  Justin T Easley; Christina L M Maruyama; Ching-Shuen Wang; Olga J Baker
Journal:  Physiol Rep       Date:  2016-10

Review 10.  Endogenous receptor agonists: resolving inflammation.

Authors:  Gerhard Bannenberg; Makoto Arita; Charles N Serhan
Journal:  ScientificWorldJournal       Date:  2007-09-01
View more
  9 in total

1.  Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.

Authors:  Kaustubh Parashar; Fabian Schulte; Markus Hardt; Olga J Baker
Journal:  FASEB J       Date:  2020-04-11       Impact factor: 5.191

2.  Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.

Authors:  Spencer Dean; Ching-Shuen Wang; Kihoon Nam; Christina L Maruyama; Bryan G Trump; Olga J Baker
Journal:  Rheumatology (Oxford)       Date:  2019-07-01       Impact factor: 7.580

3.  Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.

Authors:  Vasundhara Kain; Jeevan Kumar Jadapalli; Bochra Tourki; Ganesh V Halade
Journal:  Pharmacol Res       Date:  2019-06-16       Impact factor: 7.658

4.  Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.

Authors:  Harim Tavares Dos Santos; Kihoon Nam; Frank Maslow; Bryan Trump; Olga J Baker
Journal:  Ann Diagn Pathol       Date:  2021-11-17       Impact factor: 2.090

Review 5.  Lipoxin alleviates oxidative stress: a state-of-the-art review.

Authors:  You Zhou; Chong-Ge You
Journal:  Inflamm Res       Date:  2022-08-10       Impact factor: 6.986

6.  Pro-Resolving Mediator Annexin A1 Regulates Intracellular Ca2+ and Mucin Secretion in Cultured Goblet Cells Suggesting a New Use in Inflammatory Conjunctival Diseases.

Authors:  Anne V Lyngstadaas; Markus V Olsen; Jeffrey A Bair; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.

Authors:  Venkata Kashyap Yellepeddi; Olga J Baker
Journal:  Clin Exp Dent Res       Date:  2019-12-19

8.  Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts.

Authors:  Xiaochen Liu; Chunmeng Wang; Liping Pang; Liangliang Pan; Qi Zhang
Journal:  Cell Prolif       Date:  2022-04-11       Impact factor: 8.755

Review 9.  Formyl peptide receptors in the mucosal immune system.

Authors:  Yu Sun Jeong; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2020-10-20       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.